NuoYi MaiEr's Innovative Neosprout Nasal Hemostatic Sponge Receives MDR CE Certification

Recently,Neo Modulus' independently developed innovative medical device, Neosprout Nasal Hemostatic Sponge, has officially obtained the MDR CE certificate issued by the EU Notified Body, BSI British Standards Institution.Under the new MDR regulations, CE certification has imposed stricter requirements and thresholds on the quality systems of medical device manufacturers as well as the safety, efficacy, and market supervision of products. Neosprout Nasal HemostasisSponges for nasal packing to stop bleeding and postoperative healing have been approved for marketing. This approval signifies that the product has reached the highest international standards in terms of stability, clinical efficacy, and safety. It has gained widespread recognition in Europe and many countries and regions globally, laying a solid foundation for further expansion into the international market and clinical application, providing a "Chinese solution" for new types of nasal packing to stop bleeding.

Chronic Rhinosinusitis (CRS), as a common heterogeneous upper respiratory tract inflammatory disease, has a prevalence rate as high as 10.9%~11.9% in Europe and America, and is on the rise, significantly impacting patients' quality of life. Currently, although Functional Endoscopic Sinus Surgery (FESS) is the mainstream treatment for severe CRS, postoperative issues such as wound bleeding, secondary damage from hemostatic materials, and adhesions in the surgical cavity often occur. Therefore, the choice of nasal packing material is crucial for postoperative recovery. Neosprout is an expandable and biodegradable nasal hemostatic sponge, developed byNaturalMade from the polymer material hydroxyethyl cellulose, it possesses shape memory, is both elastic and malleable, and is biodegradable, providing a new option for clinical use as an ideal packing hemostatic material.

Meanwhile, Neo Modulus Reports Progress in Its Internationalization ProcessFrequently ReportedWith its excellent quality and innovative strength, multiple products from the company have been approved for marketing in several countries including Vietnam and Indonesia, bringing strong momentum and confidence to Neo Modulus in continuously expanding its international markets.

Neo Modulus Chairman Zhang Wencai stated, "The CE certification of Neosprout Nasal Hemostatic Sponge not only marks another breakthrough in Neo Modulus' global strategic layout but also represents an important milestone for the company as it steps into the global market. Taking this as an opportunity, we will continue to deepen our development philosophy of 'Innovated in China, Leading Globally,' further expand our overseas market presence, and bring more high-quality, high-tech medical products to the world, contributing more Chinese wisdom and strength to the advancement of global healthcare."